Resveratrol-Enhanced Human Neural Stem Cell-Derived Exosomes Mitigate MPP+-Induced Neurotoxicity Through Activation of AMPK and Nrf2 Pathways and Inhibition of the NLRP3 Inflammasome in SH-SY5Y Cells
Life,
Journal Year:
2025,
Volume and Issue:
15(2), P. 294 - 294
Published: Feb. 13, 2025
Parkinson's
disease
(PD)
is
a
progressive
neurodegenerative
disorder
primarily
characterized
by
the
loss
of
dopaminergic
neurons
in
substantia
nigra.
Mitochondrial
dysfunction,
oxidative
stress,
and
neuroinflammation
are
recognized
as
critical
pathological
mechanisms
driving
neurodegeneration
PD.
Exosome
(Exo)-based
therapies,
particularly
those
derived
from
human
neural
stem
cells
(hNSCs),
offer
promising
neuroprotective
effects
due
to
their
ability
transfer
bioactive
molecules
that
modulate
cellular
processes.
Resveratrol
(RES),
polyphenolic
compound
with
potent
antioxidant
anti-inflammatory
properties,
has
been
shown
enhance
therapeutic
potential
cell
(SC)-derived
Exos.
This
study
investigated
RES-treated
hNSCs-derived
Exos
(RES-hNSCs-Exos)
on
SH-SY5Y
exposed
1-methyl-4-phenylpyridinium
(MPP+),
neurotoxin
commonly
used
model
Parkinsonian
neurotoxicity.
Treating
MPP+
led
significant
reductions
viability,
mitochondrial
increased
activation
inflammatory
pathways.
Treatment
RES-hNSCs-Exos
rescued
MPP+-induced
toxicity
improving
enhancing
ATP
production,
increasing
biogenesis,
reducing
reactive
oxygen
species
(ROS)
generation.
The
findings
also
demonstrated
expression
essential
genes
involved
such
PGC1α,
NRF1,
Tfam,
indicating
improved
function
presence
RES-hNSCs-Exos.
Further
analysis
revealed
these
protective
were
mediated
activating
AMP-activated
protein
kinase
(AMPK)
Nrf2
signaling
pathways,
which
promoted
health
reduced
stress.
Moreover,
treatment
suppressed
downregulating
NLRP3
inflammasome
secretion
pro-inflammatory
cytokines
IL-1β
IL-18.
In
conclusion,
results
suggest
exhibit
against
neurotoxicity
function,
inhibiting
neuroinflammation.
These
highlight
hNSCs-Exos
novel
strategy
for
diseases
like
PD,
RES
valuable
enhancer
efficacy.
Language: Английский
Nanoparticle Strategies for Treating CNS Disorders: A Comprehensive Review of Drug Delivery and Theranostic Applications
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(24), P. 13302 - 13302
Published: Dec. 11, 2024
This
review
aims
to
address
the
significant
challenges
of
treating
central
nervous
system
(CNS)
disorders
such
as
neurodegenerative
diseases,
strokes,
spinal
cord
injuries,
and
brain
tumors.
These
are
difficult
manage
due
complexity
disease
mechanisms
protective
blood–brain
barrier
(BBB),
which
restricts
drug
delivery.
Recent
advancements
in
nanoparticle
(NP)
technologies
offer
promising
solutions,
with
potential
applications
delivery,
neuroprotection,
neuroregeneration.
By
examining
current
research,
we
explore
how
NPs
can
cross
BBB,
deliver
medications
directly
targeted
CNS
regions,
enhance
both
diagnostics
treatment.
Key
NP
strategies,
passive
targeting,
receptor-mediated
transport,
stimuli-responsive
systems,
demonstrate
encouraging
results.
Studies
show
that
may
improve
minimize
side
effects,
increase
therapeutic
effectiveness
models
Alzheimer’s,
Parkinson’s,
stroke,
glioblastoma.
thus
represent
a
approach
for
disorder
management,
combining
delivery
diagnostic
capabilities
enable
more
precise
effective
treatments
could
significantly
benefit
patient
outcomes.
Language: Английский
Shrimp peptide QMDDQ improves scopolamine-induced memory impairments by activating the Notch1 signaling pathway
Peng-Fei Yan,
No information about this author
Junchao Wang,
No information about this author
Xiyu Zhao
No information about this author
et al.
Food Bioscience,
Journal Year:
2025,
Volume and Issue:
unknown, P. 106041 - 106041
Published: Feb. 1, 2025
Language: Английский
The effect of electric field microenvironment on the exosome secretion of PC12 cells by chitosan carbon dots
Z.Y. Li,
No information about this author
Huajun Wang,
No information about this author
Lin Zhou
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 142747 - 142747
Published: April 1, 2025
Language: Английский
miR-574-5p in epigenetic regulation and Toll-like receptor signaling
James Y. Yang
No information about this author
Cell Communication and Signaling,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Nov. 26, 2024
miR-574-5p
is
an
unusual
microRNA
(miRNA)
that
often
upregulated
or
downregulated
following
exposure
to
irradiation
toxic
chemicals;
bacterial,
parasitic
viral
infection;
and
a
variety
of
other
disease
conditions.
Canonically,
epigenetically
regulates
the
expression
many
messenger
RNAs
(mRNAs)
through
miRNA-mediated
posttranscriptional
regulation,
thereby
affecting
cellular
physiology
pathophysiology
contributing
pathogenesis
progression
diseases.
However,
recent
studies
have
established
in
addition
serving
as
fine-tuning
repressor
gene
expression,
also
stimulates
endogenous
ligand
for
Toll-like
receptor-8/7
(TLR8/7).
Indeed,
binding
TLR8/7
triggers
TLR
signaling
pathway,
leading
induction
interferons,
inflammatory
cytokines
autoimmune
signaling.
These
findings
suggest
not
only
important
epigenetic
regulator
but
immune
responses.
Abnormal
miR-574-5p-TLR8/7
has
been
shown
be
tightly
associated
with
inflammation-related
cancers
number
disorders.
can
serve
potential
biomarker
Most
importantly,
promising
therapeutic
target
treatment
prevention
human
disorders,
especially
infectious
diseases,
Language: Английский